These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 9260328)

  • 21. Animal models of IBD: linkage to human disease.
    Mizoguchi A; Mizoguchi E
    Curr Opin Pharmacol; 2010 Oct; 10(5):578-87. PubMed ID: 20860919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.
    Ihara S; Hirata Y; Koike K
    J Gastroenterol; 2017 Jul; 52(7):777-787. PubMed ID: 28534191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
    Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
    Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis.
    Panwala CM; Jones JC; Viney JL
    J Immunol; 1998 Nov; 161(10):5733-44. PubMed ID: 9820555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice.
    Chin EY; Dangler CA; Fox JG; Schauer DB
    Comp Med; 2000 Dec; 50(6):586-94. PubMed ID: 11200563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease.
    Bhan AK; Mizoguchi E; Smith RN; Mizoguchi A
    Immunol Rev; 1999 Jun; 169():195-207. PubMed ID: 10450518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sec1 regulates intestinal mucosal immunity in a mouse model of inflammatory bowel disease.
    Cai J; Wu H; Wang C; Chen Y; Zhang D; Guan S; Fu B; Jin Y; Qian C
    BMC Immunol; 2023 Dec; 24(1):51. PubMed ID: 38066482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-23 in inflammatory bowel diseases and colon cancer.
    Neurath MF
    Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse.
    Madsen KL
    Clin Invest Med; 2001 Oct; 24(5):250-7. PubMed ID: 11603509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of Pediatric Inflammatory Bowel Disease.
    Peloquin JM; Goel G; Villablanca EJ; Xavier RJ
    Annu Rev Immunol; 2016 May; 34():31-64. PubMed ID: 27168239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune aspects of the pathogenesis of inflammatory bowel disease.
    Hisamatsu T; Kanai T; Mikami Y; Yoneno K; Matsuoka K; Hibi T
    Pharmacol Ther; 2013 Mar; 137(3):283-97. PubMed ID: 23103332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues.
    Valatas V; Bamias G; Kolios G
    Eur J Pharmacol; 2015 Jul; 759():253-64. PubMed ID: 25814256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis.
    Monteleone I; MacDonald TT; Pallone F; Monteleone G
    Curr Opin Gastroenterol; 2012 Jul; 28(4):310-3. PubMed ID: 22450895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
    Alavi K; Schwartz MZ; Palazzo JP; Prasad R
    J Pediatr Surg; 2000 Jun; 35(6):847-51. PubMed ID: 10873024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal epithelial antigen induces CD4+ T cells with regulatory phenotype in a transgenic autoimmune mouse model.
    Westendorf AM; Bruder D; Hansen W; Buer J
    Ann N Y Acad Sci; 2006 Aug; 1072():401-6. PubMed ID: 17057222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.